Company intelligence / Profile preview

Tianjin Hemay Oncology Pharmaceutical

Tianjin, Tianjin/Tianjin Municipality, Chinahemay.com.cn ↗

Ownership: Private
Development stage: Other

Overview

Tianjin Hemay Oncology is an active Chinese biotech/pharma innovator specializing in novel small-molecule drugs for both oncology and immune-mediated diseases. The company has multiple late-stage clinical assets targeting high unmet needs across these domains, including two Phase III programs for advanced/metastatic ER+/HER2+ breast cancers with novel small molecules, and Mufemilast at NDA/BLA stage for plaque psoriasis. Its pipeline also covers autoimmune disorders such as rheumatoid arthritis, psoriasis, and ankylosing spondylitis, as well as hepatocellular carcinoma and non-small cell lung cancer.

Therapeutic areas: DermatologyGastroenterologyOncologyImmunologyRheumatology
Modalities: Small moleculeCytotoxic small molecule
Industry: Biotech

Drug pipeline

1 asset

Hemay022

Unknown

Partnerships

Truman CapitalHigh Estate Capital Management Limited PartnershipTigermed Investment Limited PartnershipShanghai Cenova Innovation Fund L.P.Efung Healthcare Fund L.P.

Beyond the preview

Go deeper on Tianjin Hemay Oncology Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianjin Hemay Oncology Pharmaceutical.

Explore the full profile